SCHEMBL4873473

SCHEMBL4873473

Cc1ccccc1Oc1c[nH]nc1-c1cc(Br)c(O)cc1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 4/20 0.41
MEN1 O00255 5/20 0.36
KMT2A Q03164 5/20 0.36
TSHR P16473 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
RAB9A P51151 2/20 0.36
NPC1 O15118 1/20 0.36
ESR1 P03372 1/20 0.34
ESR2 Q92731 1/20 0.34
MAPT P10636 4/20 0.34
NPSR1 Q6W5P4 2/20 0.34
KDM4E B2RXH2 1/20 0.34
CASP1 P29466 1/20 0.34
CASP7 P55210 1/20 0.34
LMNA P02545 3/20 0.33
USP2 O75604 2/20 0.33
ALDH1A1 P00352 1/20 0.33
POLB P06746 1/20 0.33
SLC6A2 P23975 2/20 0.32
SLC6A4 P31645 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4876588 0.90 HSP90AA1 (0.40) HSP90AA1MEN1KMT2ARAB9ANPC1
SCHEMBL4884673 0.86 HSP90AA1 (0.40) HSP90AA1KMT2ATSHRSMN1; SMN2ESR1
SCHEMBL4881078 0.86 HSP90AA1 (0.40) HSP90AA1ESR1ESR2MAPTLMNA
SCHEMBL4877833 0.85 HSP90AA1 (0.44) HSP90AA1MEN1KMT2ASMN1; SMN2ESR1
SCHEMBL4879596 0.85 CAMK2A (0.37) HSP90AA1MEN1KMT2AESR1ESR2
SCHEMBL4881255 0.84 HSP90AA1 (0.37) HSP90AA1MEN1KMT2ASMN1; SMN2MAPT
SCHEMBL4881567 0.83 HSP90AA1 (0.37) HSP90AA1MEN1KMT2AESR1ESR2
SCHEMBL4881715 0.82 KMT2A (0.48) HSP90AA1MEN1KMT2AESR1ESR2
SCHEMBL4879457 0.81 HSP90AA1 (0.46) HSP90AA1MEN1KMT2ASMN1; SMN2ESR1
SCHEMBL4881093 0.81 HSP90AA1 (0.44) HSP90AA1SMN1; SMN2ESR1ESR2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1799649-B1 3-(2-HYDROXYPHENYL) PYRAZOLES AND THEIR USE AS HSP90 MODULATORS MERCK PATENT GMBH (DE) 2014-06-25 EP claimed
US-20080090880-A1 3-(2-Hydroxyphenyl) Pyrazoles and Thier Use as Hsp90 Modulators MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2008-04-17 US claimed
EP-1799649-B1 3-(2-HYDROXYPHENYL) PYRAZOLES AND THEIR USE AS HSP90 MODULATORS MERCK PATENT GMBH (DE) 2014-06-25 EP disclosed
US-20080090880-A1 3-(2-Hydroxyphenyl) Pyrazoles and Thier Use as Hsp90 Modulators MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2008-04-17 US disclosed
EP-1799649-A1 3-(2-HYDROXYPHENYL) PYRAZOLES AND THEIR USE AS HSP90 MODULATORS Merck Patent GmbH (DE) 2007-06-27 EP disclosed
WO-2006039977-A1 3-(2-HYDROXYPHENYL) PYRAZOLES AND THEIR USE AS HSP90 MODULATORS MERCK PATENT GMBH (DE) 2006-04-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090880-A1 3-(2-Hydroxyphenyl) Pyrazoles and Thier Use as Hsp90 Modulators HSP90AB1, HSP90AA1, HSP90AB2P HSP90AA1 2/4885MEN1 4568/4885KMT2A 4029/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.